National Institutes of Health Funds Tuberculosis Vaccine Research at TTUHSC El Paso

NEXT STORY
CORRECTION – MassMEDIC Announces the 2021 IGNITE Accelerator Winners
PREV STORY
AXIOM MEDICAL HELPS 15 MILLION EMPLOYEES RETURN TO WORK SAFELY WITH CHECKIN2WORK APP
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Five Prime Announces First Quarter 2016 Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

author_avatar
NASDAQ Market News

Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer

At six months, 30% of patients treated with Kymriah were in complete response, with ...

author_avatar
NASDAQ Market News

The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019

author_avatar
NASDAQ Market News